AddLife AB (0REZ) Share Price & Analysis
0REZ Stock Chart & Stats
- Day’s Range
- SEK 181.60 - SEK 183.50
- 52-Week Range
- SEK 133.00 - SEK 205.60
- Previous Close
- SEK 180.70
- Volume
- 5,792
- Average Volume (3M)
- 31.85K
- Market Cap
- SEK 22.23B
- Enterprise Value
- SEK 25.63B
- Total Cash (Recent Filing)
- SEK 477.00M
- Total Debt (Recent Filing)
- SEK 5.14B
- Price to Earnings (P/E)
- 34.7
- Beta
- 1.18
- Next Earnings
- Feb 03, 2027 (Est.)
- EPS Estimate
- 1.38
- Last Dividend Ex-Date
- May 07, 2026
- Dividend Yield
- 0.82%
Bulls Say, Bears Say
Bulls Say
Earnings And Revenue Growth
AddLife is combining organic and acquired growth with faster earnings expansion, indicating improving operating leverage and customer demand. Continued sales progress across Labtech and Medtech, alongside higher adjusted EBITA, can strengthen reinvestment capacity and support durable earnings development.
Strong Cash Generation
Strong operating and free cash flow provide internal funding for acquisitions, product investments and debt obligations without relying entirely on external financing. Free cash flow equal to about 81% of net income also supports earnings quality and gives management greater flexibility over several quarters.
Advanced Products And Selective Acquisitions
The shift toward advanced products and carefully selected acquisitions can improve AddLife’s mix and raise profitability over time. Management reports that acquired businesses earn margins well above the group average, while advanced portfolios support healthcare efficiency and deeper customer relationships.
Bears Say
Margin Pressure
Despite higher earnings, lower EBIT and EBITDA margins show that cost, mix or investment pressures are limiting conversion of revenue into operating profit. Sustained margin pressure could reduce the benefit of growth and make management’s margin-expansion programs more important to future results.
Meaningful Debt Burden
Leverage has improved, but the absolute debt load remains material and reduces financial flexibility if operating conditions weaken. Debt obligations can compete with acquisition and product investment needs, while a downturn or weaker cash conversion could make balance-sheet management more demanding.
Ongoing Spain Operating Disruption
The unresolved dispute creates an ongoing risk to surgical procedures and local operating activity rather than a purely historical setback. Further strikes could delay customer demand and weigh on regional performance, making recovery dependent on an external resolution that management does not control.
0REZ FAQ
What was AddLife AB’s price range in the past 12 months?
What is AddLife AB’s market cap?
When is AddLife AB’s upcoming earnings report date?
How were AddLife AB’s earnings last quarter?
Is AddLife AB overvalued?
Does AddLife AB pay dividends?
What is AddLife AB’s EPS estimate?
How many shares outstanding does AddLife AB have?
What happened to AddLife AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of AddLife AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
AddLife AB
AddLife AB (publ), a company established in 1906 and headquartered in Stockholm, Sweden, specializes in delivering cutting-edge equipment, medical apparatus, and chemical reagents. Its primary clientele includes the healthcare sector, academic and research organizations (such as colleges and universities), and key players within the food and pharmaceutical industries. The firm's operations are divided into two distinct divisions: Labtech and Medtech. The Labtech segment provides a comprehensive array of products, integrated solutions, and expert services, focusing on diagnostics, biomedical research, and general laboratory requirements. This encompasses specialized instruments for areas like haematology, pathology, immediate diagnostic testing (point-of-care), cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, along with consumables and advanced analytical machinery. This division further offers vital support, maintenance, consultancy, and educational programs. Conversely, the Medtech segment concentrates on supplying a wide range of medical devices tailored for critical applications such as surgical procedures, respiratory support, intensive care, wound management, and enteral nutrition. It also develops products for fall prevention, welfare technology, and ear, nose, and throat conditions, in addition to offering specific assistive devices for bathrooms and specialized aids for children with disabilities. AddLife maintains a broad international presence, conducting business in its home country of Sweden, across the Nordics (Finland, Denmark, Norway), the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, other parts of Europe, and globally.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Fredrik Dalborg
- Employees
- 2,360
- Website
- www.add.life
- Address
- Brunkebergstorg 5, Stockholm, AB, 103 62, SE
AddLife AB (0REZ) Earnings & Revenues
0REZ Company Deck
0REZ Earnings Call
Earnings Call SentimentPositive
The call was strongly positive overall. Sales, adjusted EBITA, profit before tax, margins and operating cash flow all improved, Labtech performed particularly well, regional activity improved in the U.K. and Eastern Europe, and acquisition activity and the pipeline strengthened. The main challenges were the Medtech margin decline, unusually high operating expenses related to explicitly stated growth and acquisition activities, the ongoing dispute in Spain, seasonal softness, higher inventory and a foreign-exchange-driven increase in net debt.
View all GB:0REZ earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 5 | 1 |
| Technical Analysis | 5 | 5 | 0 |
| Moving Averages | 11 | 0 | 1 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| SE:ARJO.BArjo AB | ||
| SE:CEVICellaVision AB | ||
| SE:NOLA.BNolato AB | ||
| SE:BACTI.BBactiguard Holding AB | ||
| SE:STILStille AB |